Pretreatment of bone with osteoclasts affects phenotypic expression of osteoblast-like cells

Journal of Orthopaedic Research

Volumn 21, Issue 4, 2003, Pages 638-647

  Boyan, Barbara D ^a,b   Schwartz, Z ^a,b,c   Lohmann, C H ^b,d   Sylvia, V L ^b   Cochran, D L ^b   Dean, D D ^b   Puzas, J E ^e  

^a Emory University   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d UNIVERSITY OF HAMBURG   (Germany)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bone wafers; Differentiation; Osteoblasts; Osteoclasts; Surface morphology

Indexed keywords

BONE; ENZYMES; SURFACES;

OSTEOCLASTS AFFECTS;

CELLS;

ALKALINE PHOSPHATASE; OSTEOCALCIN; PLASTIC; PROSTAGLANDIN E2; TITANIUM; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; BONE REMODELING; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SPECIFICITY; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; RAT; REVIEW; SURFACE PROPERTY; TIME;

EID: 0037869520     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-0266(02)00261-9     Document Type: Review

References (42)

1. 3. J Biomed Mater Res 1998; 41:489-96.
2. Ber R, Kubota T, Sodek J, Aubin JE. Effects of transforming growth factor-beta on normal clonal bone cell populations. Biochem Cell Biol 1991;69:132-40.
3. 3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem 1992;267:8943-9.
4. 3 and transforming growth factor beta (TGF beta). Bone Miner 1992;17:139-44.
5. 3. J Biomed Mater Res 1998;39:77-85.
6. Boyan BD, Bonewald LF, Paschalis EP, Lohmann CH, Rosser J, Cochran DL, et al. Osteoblast-mediated mineral deposition in culture is dependent on surface microtopography. Calcif Tissue Int, in press.
7. Boyan BD, Dean DD, Lohmann CH, Cochran DL, Sylvia VL, Schwartz Z. The titanium-bone cell interface in vitro: the role of the surface in promoting osteointegration. In: Brunette DM, Tengvall P, Textor M, Thomsen P, editors. Titanium in Medicine. Berlin, Germany: Springer-Verlag; 2001. p. 561-85.
8. Boyan BD, Lohmann CH, Dean DD, Sylvia VL, Cochran DL, Schwartz Z. Mechanisms involved in osteoblast response to implant surface morphology. In: Stupp SI, Clarke DR, Ruhle M, Bravman JC, Forrest SR, editors. Annual Review of Materials Research. Palo Alto, CA: Annual Reviews; 2001. p. 357-71.
9. Boyan BD, Lohmann CH, Sisk M, Liu Y, Sylvia VL, Cochran DL, et al. Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness. J Biomed Mater Res 2001;55:350-9.
10. 3 responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture. J Biol Chem 1989;264:11879-86.
11. Boyde A, Ali NN, Jones SJ. Optical and scanning electron microscopy in the single osteoclast resorption assay. Scan Electron Microsc 1985;3:1259-71.
12. Bretaudiere JP, Spillman T. Alkaline phosphatases. In: Bergmeyer HU, editor. Methods of enzymatic analysis. Weinheim, Germany: Verlag Chemica; 1984. p. 75-92.
13. Dodds RA, Connor JR, James IE, Rykaczewski EL, Appelbaum E, Dul E, et al. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone. J Bone Miner Res 1995;10:1666-80.
14. Ek-Rylander B, Flores M, Wendel M, Heinegard D, Andersson G. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 1994;269:14853-6.
15. Everts V, Delaisse JM, Korper W, Niehof A, Vaes G, Beertsen W. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol 1992;150:221-31.
16. 3 specific regulation of growth, morphology, and fibronectin in a humanosteosarcoma cell line. J Cell Physiol 1985;123:401-9.
17. Fuller K, Thong JTL, Breton BC, Chambers TJ. Automated three-dimensional characterization of osteoclastic resorption lacunae by stereoscopic scanning electron microscopy. J Bone Miner Res 1994;9:17-23.
18. Gerstenfeld LC, Chipman SD, Glowacki J, Lian JB. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Develop Biol 1987;122:49-60.
19. Hale LV, Kemick ML, Wuthier RE. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture. J Bone Miner Res 1986;1:489-95.
20. Kapanen A, Kinnunen A, Ryhanan J, Tuukkanen J. TGF-beta 1 secretion of ROS-17/2.8 cultures on NiTi implant material. Biomaterials 2002;23:3341-6.
21. Kieswetter K, Schwartz Z, Hummert TW, Cochran DL, Simpson J, Dean DD, et al. Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG63 cells. J Biomed Mater Res 1996;32:55-63.
22. Klein-Nulend J, Semeins CM, Burger EH. Prostaglandin-mediated modulation of transforming growth factor-beta metabolism in primary mouse osteoblastic cells in vitro. J Cell Physiol 1996;168:1-7.
23. Lian JB, Stein GS. The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGFβ1) and hormones (vitamin D and glucocorticoids). J Oral Implantol 1993;19:95-105.
24. 3. J Bone Miner Res 2000;15:1169-80.
25. Lohmann CH, Tandy EM, Sylvia VL, Hell-Vocke AK, Cochran DL, Dean DD, et al. Response of normal female human osteoblasts (NHOst) to 17β-estradiol is modulated by implant surface morphology. J Biomed Mater Res, submitted for publication.
26. Martin JY, Schwartz Z, Hummert TW, Schraub DM, Simpson J, Lankford J, et al. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res 1995;29:389-401.
27. Ong JL, Bess EG, Bessho K. Osteoblast progenitor cell responses to characterized titanium surfaces in the presence of bone morphogenetic protein-atelopeptide type I collagen in vitro. J Oral Implantol 1999;25:95-100.
28. Ong JL, Cardenas HL, Cavin R, Carnes Jr DL. Osteoblast responses to BMP-2-treated titanium in vitro. Int J Oral Maxillofac Impl 1997;12:649-54.
29. Ong JL, Carnes DL, Cardenas HL, Cavin R. Surface roughness of titanium on bone morphogenetic protein-2-treated osteoblast cells in vitro. Impl Dent 1997;6:19-24.
30. Puzas JE, Lewis G, Hsu J, Reynolds PR, Rosier RN, O'Keefe RJ, et al. Osteoblasts preferentially adhere to sites of prior bone resorption. J Bone Min Res 1997;12:S413.
31. Puzas JE, Sheu TJ, Schwartz EM, O'Keefe RJ, Rosier RN. An osteoblast phage display library identifies TRIP to have high affinity for TRAP. J Bone Miner Res 2001;16(1):164.
32. 2 on bone formation in cultured fetal rat calvariae: Interaction with cortisol. Endocrinology 1998;126:1654-9.
33. Raisz LG, Pilbeam CC, Fall PM. Prostaglandins: mechanisms of action and regulation of production in bone. Osteoporosis Int 1993;3:136-40.
34. Scheven BA, Marshall D, Aspden RM. In vitro behaviour of human osteoblasts on dentin and bone. Cell Biol Int 2002;26:337-46.
35. 3 in three osteoblast-like cell lines (MC-3T3-E1, ROS 17/2.8, and MG-63). Bone 1992;13:51-8.
36. Schwartz Z, Lohmann CH, Oefinger J, Bonewald LF, Dean DD, Boyan BD. Implant surface characteristics modulate differentiation behavior of cells in the osteoblastic lineage. Adv Dent Res 1999;13:38-48.
37. 3 is mediated via protein kinase C- and protein kinase A-dependent pathways. Biomaterials 2001;22:731-41.
38. 3 is mediated through the mitogen activated protein (MAP) kinase pathway. J Biomed Mater Res 2001;56:417-26.
39. Schwartz Z, Lohmann CH, Wieland M, Cochran DL, Dean DD, Textor M, et al. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts. J Periodontol 2000;71:586-97.
40. Sheu TJ, Schwartz EM, O'Keefe RJ, Rosier RN, Puzas JE. Use of a phage display technique to identify potential osteoblast binding sites within osteoclast lacunae. J Bone Min Res 2002;17:915-22.
41. Sisk M, Lohmann CH, Cochran DL, Sylvia VL, Simpson JP, Dean DD, et al. Inhibition of cyclooxygenase by indomethacin modulates osteoblast response to titanium surface roughness in a time-dependent manner. Clin Oral Implants Res 2001;12:52-61.
42. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.